| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acumen Pharmaceuticals, Inc. (ABOS) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. ABOS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 893.3K | $2.26M | - | |
| CFO | 309.1K | $780.4K | - | |
| Other | 258.6K | $653.0K | - | |
| Pres | 220.9K | $557.8K | - | |
| COO | 126.9K | $320.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Meisner Derek M64 | Chief Legal Officer &Corp Sec | Sell | 11,122 | $1.84 | $20,505.63 | -10.2% | -48.0% | +6.3% | |
| Jan 3, 2025 | Barton Russell51 | Chief Operating Officer | Sell | 7,636 | $1.86 | $14,225.10 | -7.9% | -48.0% | +6.3% | |
| Jan 3, 2025 | Zuga Matt51 | CFO &Chief Business Officer | Sell | 13,235 | $1.84 | $24,366.96 | -6.3% | -48.0% | +6.3% | |
| Jan 3, 2025 | Siemers Eric49 | Chief Medical Officer | Sell | 10,859 | $1.85 | $20,046.80 | -9.2% | -48.0% | +6.3% | |
| Jan 19, 2024 | Oconnell Daniel Joseph53 | President And CEO | Sell | 15,200 | $3.47 | $52,753.12 | -2.9% | -12.7% | -54.4% | |
| Jan 19, 2024 | Meisner Derek M64 | Chief Legal Officer &Corp Sec | Sell | 8,933 | $3.48 | $31,048.43 | -7.6% | -12.7% | -54.4% | |
| Jan 18, 2024 | Zuga Matt51 | CFO &Chief Business Officer | Sell | 4,242 | $3.71 | $15,716.61 | -2.0% | -5.7% | -55.2% | |
| Jan 18, 2024 | Siemers Eric49 | Chief Medical Officer | Sell | 3,124 | $3.71 | $11,603.79 | -2.6% | -5.7% | -55.2% | |
| Jan 18, 2024 | Barton Russell51 | Chief Operating Officer | Sell | 2,833 | $3.73 | $10,555.19 | -2.8% | -5.7% | -55.2% | |
| Aug 17, 2023 | Ives Jeffrey L.68 | Director | Sale+OE | 41,949 | $6.49 | $272,333.52 | -100% | -63.0% | -59.8% |